CROSSJECT (STU:74C) FFO


STU:74C CROSSJECT STU:74C
46 GF Score
Price €1.81
GF Value €1.19
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CROSSJECT FFO?

FFO (Funds from operations) only applies to REITs.

STU:74C
46GF Score
CROSSJECT STU:74C
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CROSSJECT (STU:74C) Overvalued in 2026?

Based on GuruFocus' analysis, CROSSJECT stock appears to be overvalued. The current stock price of €1.81 is trading 52.1% above its estimated GF Value™ of €1.19. GuruFocus considers CROSSJECT to be Significantly Overvalued.

Key valuation signals for STU:74C:

  • FFO:
  • GF Value™: €1.19 vs. price of €1.81 (52.1% above fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the STU:74C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CROSSJECT Business Description

Other Exchanges ALCJ:France
Address 60L avenue du 14 Juillet, Chenôve, FRA, 21300
CROSSJECT manufactures and markets needle-free drug self-injection system.
46GF Score

Get the complete analysis for STU:74C

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.81
Price
€1.19
GF Value